Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial Cancer [NA]
A clinical trial investigating whether motivational interviewing reduces post-traumatic stress symptoms and enhances posttraumatic growth am…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. [Phase 1]
Phase 1 clinical trial update for COM701, a PVRIG inhibitor, in adults with advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2025-01-15Clinical Trial Update: A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors [Phase 1]
A Phase 1 trial evaluating ASP1893 in adults with CLDN6-positive solid tumors has been withdrawn.
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors [NA]
A multimodal PET imaging study for the diagnosis and treatment of pelvic tumors in endometrial cancer is currently recruiting at Peking Unio…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial [Phase 2]
A Phase 2 multicenter randomized open-label trial evaluating adebrelimab plus carboplatin/paclitaxel followed by adebelizumab, with or witho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Onapristone and Anastrozole for refractory hormone receptor-positive endometrial cancer…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer [Phase 3]
Phase 3 study evaluating Fruquintinib in combination with Sintilimab for advanced endometrial cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator
Clinical trial update evaluating five-year overall survival and disease-free survival in endometrial cancer patients undergoing total laparo…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: MK-3475 Immunotherapy in Endometrial Carcinoma [Phase 1]
Phase 1 trial evaluating pembrolizumab (MK-3475) in endometrial cancer has completed, with results posted.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating QL1706 in combination with chemotherapy for recurrent or metastatic endometrial cancer; status is not yet …
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer [Phase 2]
A Phase 2 study of ONC201 as a single agent in recurrent or metastatic endometrial cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer [Phase 2]
A Phase 2 study of ONC201 in recurrent Type II endometrial cancer was terminated, with results posted on 2024-12-24.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oral AMXT 1501 Dicaprate in Combination With IV DFMO [Phase 1, Phase 2]
A Phase 1/2 trial of oral AMXT 1501 dicaprate in combination with IV DFMO has been terminated.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia
Describes a multi-center prospective study evaluating oncological outcomes, reproductive outcomes, and quality of life after fertility-spari…
-
CLINICAL_TRIALS withdrawal · 2024-12-19Clinical Trial Update: Niraparib in High-grade Endometrial Cancer Trial [EARLY_Phase 1]
A Phase 1 Niraparib trial for high-grade endometrial cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients [Phase 2]
Phase 2 trial evaluating metformin in combination with a levonorgestrel-releasing intrauterine system for Complex atypical hyperplasia of th…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer
This entry reports on a clinical trial evaluating clinical and molecular biomarkers in immunotherapy treatment for gynecologic cancers, focu…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 trial evaluating NC410 in combination with pembrolizumab for advanced unresectable or metastatic solid tumors across mul…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
The PRODIGYN study is a prospective trial evaluating the added prognostic and diagnostic value of medical imaging in gynecologic cancers and…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer [Phase 3]
A Phase 3 trial evaluating enhanced recovery after surgery (ERAS) protocols for laparoscopic hysterectomy in low-risk endometrial cancer has…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Comprehensive Outcomes for After Cancer Health [NA]
A clinical trial update from Pack Health indicates the study on comprehensive outcomes for after-cancer health is currently recruiting, cove…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer [Phase 4]
A Phase 4 clinical trial is evaluating Akynzeo (netupitant/palonosetron) as an antiemetic in patients with endometrial cancer and is current…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: PErsonalized TReatment for Endometrial Carcinoma [NA]
A University of Helsinki-sponsored clinical trial is currently recruiting to evaluate personalized treatment for endometrial adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: UTOLA: UTerin OLAparib [Phase 2]
Phase 2 trial of olaparib for endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells [NA]
A completed clinical trial conducted in Thailand evaluating the effectiveness of metformin on a proliferative marker in endometrial cancer c…